- Conditions: cUTI; Complicated Urinary Tract Infection; Acute Pyelonephritis
Interventions: Drug: CAZ-AVI; Drug: Doripenem
Sponsors: AstraZeneca; AstraZeneca; Cerexa, Inc.
Not yet recruiting - verified May 2012 - Condition: Hypercholesterolemia
Interventions: Other: 1- Low fat drinkable fermented dairy product enriched with 1.6g of plant sterol (as free equivalent) per unit; Other: 2- Low fat drinkable fermented dairy product enriched with 2.0g of plant sterol (as free equivalent) per unit; Other: 3- Low fat drinkable fermented dairy product without plant sterols(control)
Sponsors: Danone Research; Danone Spain; DEPARTMENT OF INTERNAL MEDICINE. HOSPITAL DE SANT JOAN
Completed - verified May 2012 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: theophylline; Other: placebo
Sponsors: Hospital Son Espases; Hospital Son Espases; Spanish Research Center for Respiratory Diseases; Fundación Mutua Madrileña
Recruiting - verified May 2012 - Condition: Tension-type Headache
Interventions: Other: Manual Therapy; Other: Manual Therapy; Other: Manual Therapy; Other: placebo treatment
Sponsors: University of Valencia; University of Valencia
Completed - verified May 2012 - Condition: Allergy to Mites
Intervention: Biological: Four different concentrations of Blomia tropicalis allergen extract, positive control and negative control
Sponsors: Laboratorios Leti, S.L.; Laboratorios Leti, S.L.
Recruiting - verified May 2012 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Roflumilast 500; Drug: Placebo
Sponsors: Spanish Research Center for Respiratory Diseases; Spanish Research Center for Respiratory Diseases
Not yet recruiting - verified May 2012 - Condition: Cardiovascular Risk Factors
Intervention: Dietary Supplement: Cocoa extract
Sponsors: Instituto Cientifico y Tecnologico de Navarra, Universidad de Navarra; Instituto Cientifico y Tecnologico de Navarra, Universidad de Navarra; University of Navarra
Active, not recruiting - verified May 2012 - Condition: Ambulatory Rizarthrosis Surgery
Interventions: Drug: Levobupivacaine; Other: No intervention
Sponsors: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau; Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau; CAIBER Sant Pau, Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau - IIB Sant Pau; Clinical Research Ethics Committee, Hospital de la Santa Creu i Sant Pau; Anesthesiology Service, Hospital de la Santa Creu i Sant Pau
Not yet recruiting - verified March 2012 - Condition: Cardiac Surgery
Intervention:
Sponsors: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau; Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Recruiting - verified January 2012 - Condition: Cardiac Surgery
Interventions: Drug: Levosimendan; Drug: Placebo
Sponsors: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau; Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Recruiting - verified May 2012 - Condition: Thrombosis
Intervention: Other: D Dimer and ultrasonography
Sponsors: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau; Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Recruiting - verified April 2011 - Conditions: HER2 + Breast Cancer; HER2 + Gastric Cancer; Squamous Cell Carcinoma of Head and Neck
Intervention: Drug: LJM716
Sponsors: Novartis; Novartis Pharmaceuticals
Not yet recruiting - verified May 2012 - Condition: Blood Loss
Interventions: Drug: Tranexamic Acid; Drug: Tranexamic Acid; Other: haemostasia
Sponsors: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau; Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Recruiting - verified May 2012 - Condition: Tooth Extraction
Interventions: Drug: Placebo; Drug: TT-173
Sponsors: Thrombotargets Europe S.L; Thrombotargets Europe S.L
Recruiting - verified May 2012 - Condition: Patent Ductus Arteriosus
Interventions: Drug: Ibuprofen EchoG; Drug: Standard ibuprofen treatment
Sponsors: Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz; Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz
Completed - verified May 2012 - Condition: Type 2 Diabetes
Interventions: Drug: Liraglutide + metformin; Drug: Glimepiride + metformin
Sponsors: Fundación Fernández-Cruz; Fundación Fernández-Cruz
Not yet recruiting - verified May 2012 - Condition: Leiomyomas
Intervention: Genetic: Laparoscopic myomectomy. Following analysis and proliferation of cells isolated from removed human leiomyoma.
Sponsors: Instituto Valenciano de Infertilidad, Spain; Instituto Valenciano de Infertilidad, Spain
Recruiting - verified May 2012 - Condition: Influenza
Interventions: Procedure: Throat swab and/or nasopharyngeal swab; Other: Data collection
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified May 2012 - Condition: Hepatitis C, Chronic
Interventions: Drug: boceprevir; Drug: peginterferon alfa-2a [Pegasys]; Drug: ribavirin (Copegus]; Drug: peginterferon alfa-2a [Pegasys]; Drug: ribavirin (Copegus]
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Not yet recruiting - verified May 2012 - Conditions: Allergic Rhinitis; Rhinoconjunctivitis; Mild Persistent Asthma; Mild Intermittent Asthma
Intervention: Biological: Depigoid® (500 DPP/ml)
Sponsors: Laboratorios Leti, S.L.; Laboratorios Leti, S.L.; Harrison Clinical Research
Not yet recruiting - verified May 2012 - Condition: Branch Retinal Vein Occlusion
Interventions: Drug: Ranibizumab; Procedure: Laser
Sponsors: Novartis; Novartis Pharmaceuticals
Not yet recruiting - verified May 2012 - Condition: Mechanical Low Back Pain
Interventions: Other: Resonant oscillation; Other: column exercise group
Sponsors: Omphis Foundation; Omphis Foundation
Recruiting - verified May 2012 - Condition: Pulmonary Embolism
Interventions: Drug: Diclofenac; Drug: Placebo
Sponsors: Ministry of Health, Spain; Ministry of Health, Spain
Not yet recruiting - verified May 2012 - Condition: Primary Molar Pulpotomy
Interventions: Other: Pulpotomy; Other: Pulpotomy
Sponsors: Universitat Internacional de Catalunya; Cristina Cuadros
Recruiting - verified May 2012 - Condition: Familial Chylomicronemia Syndrome (FCS) (HLP Type I)
Intervention: Drug: LCQ908
Sponsors: Novartis; Novartis Pharmaceuticals
Not yet recruiting - verified April 2012 - Condition: Ectopic Pregnancies
Intervention:
Sponsors: Instituto Valenciano de Infertilidad, Spain; Instituto Valenciano de Infertilidad, Spain
Recruiting - verified May 2012 - Conditions: Fibrosis; Renal Failure; Hepatorenal Syndrome
Interventions: Drug: Albumin; Drug: Midodrine; Drug: Octreotide
Sponsors: Fundacion Clinic per a la Recerca Biomédica; Fundacion Clinic per a la Recerca Biomédica
Not yet recruiting - verified April 2012 - Condition: Endometrial Receptivity Failure
Intervention: Other: Lipid identification
Sponsors: Instituto Valenciano de Infertilidad, Spain; Instituto Valenciano de Infertilidad, Spain
Recruiting - verified April 2012 - Conditions: Grand Mal Status Epilepticus; Non-convulsive Status Epilepticus
Intervention: Drug: valproic acid (VPA)
Sponsors: Hospital Universitari de Bellvitge; Hospital Universitari de Bellvitge; Hospital Vall d'Hebron; Germans Trias i Pujol Hospital; Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta; Hospital Clinic of Barcelona
Recruiting - verified May 2012 - Conditions: Catheter-related Bloodstream Infection.; Bacteremia.
Interventions: Drug: Administration of vancomycin in antibiotic lock solution; Drug: Administration of teicoplanin in antibiotic lock solution; Drug: Administration of linezolid in antibiotic lock solution; Drug: Administration of daptomycin in antibiotic lock solution; Drug: Administration of tigecycline in antibiotic lock solution
Sponsors: Instituto Cientifico y Tecnologico de Navarra, Universidad de Navarra; Instituto Cientifico y Tecnologico de Navarra, Universidad de Navarra; University of Navarrra Hospital (Clinica Universitaria)
Not yet recruiting - verified May 2012 - Conditions: Osteoarthritis, Knee; Knee Arthrosis; Knee Osteoarthritis
Interventions: Other: Injection of Mesenchymal Stromal Cells; Drug: Hyaluronic Acid
Sponsors: Red de Terapia Celular; Red de Terapia Celular; Scientific Park Foundation, University of Valladolid; Instituto de Biologia y Genetica Molecular (IBGM), University of Valladolid; Sanidad de Castilla y Leon (SACYL); Centro Medico Teknon
Recruiting - verified April 2012 - Condition: Extremely Complex Perianal Fistulae
Intervention: Drug: Adipose-derived stem cells without expanded
Sponsors: Instituto de Investigación Hospital Universitario La Paz; Instituto de Investigación Hospital Universitario La Paz
Recruiting - verified April 2012 - Condition: Granulosa Cell Tumour of the Ovary
Intervention: Drug: Ketoconazole
Sponsors: Grupo Español de Tumores Huérfanos e Infrecuentes; Grupo Español de Tumores Huérfanos e Infrecuentes
Not yet recruiting - verified April 2012 - Conditions: Diphtheria,; Tetanus and Pertussis
Intervention:
Sponsors: Sanofi Pasteur MSD; Sanofi Pasteur MSD; Oxon Epidemiology/ Chiltern; Dr. José Garcia Sicilia-López; Dr. Francisco Giménez
Recruiting - verified April 2012 - Condition: Breast Cancer Invasive Nos
Intervention:
Sponsors: Spanish Breast Cancer Research Group; Spanish Breast Cancer Research Group; Hoffmann-La Roche; Roche Farma, S.A.
Not yet recruiting - verified May 2012 - Conditions: Guillain-Barré Syndrome; Miller Fisher Syndrome
Intervention:
Sponsors: Erasmus Medical Center; Erasmus Medical Center
Recruiting - verified May 2012 - Condition: Glioblastoma
Interventions: Drug: LY2157299 monohydrate; Drug: Lomustine; Drug: Placebo
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Phase I Mass Balance, PK and Safety Study of 14C-Labeled Belinostat in Patients With Advanced CancerCondition: Advanced Cancer
Intervention: Drug: Belinostat
Sponsors: Spectrum Pharmaceuticals, Inc; Spectrum Pharmaceuticals, Inc
Not yet recruiting - verified April 2012 - Condition: HIV
Intervention: Drug: Lopinavir/ritonavir 800 mg / 200mg
Sponsors: Hospital Universitari de Bellvitge; Daniel Podzamczer
Not yet recruiting - verified April 2012 - Study to Reduce Duration of Antibiotic Therapy in Haematological Patients With Fever and NeutropeniaCondition: Febrile Neutropenia
Interventions: Other: Empirical antimicrobial treatment discontinuation; Other: Standard empirical antimicrobial treatment discontinuation
Sponsors: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla; Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Recruiting - verified April 2012
 |
Find Paid Clinical Trials in Spain |
Clinical Trial Locations 